Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Philip M. Kemp is active.

Publication


Featured researches published by Philip M. Kemp.


Clinical Eeg and Neuroscience | 2003

Acute Marihuana (THC) Exposure Produces a “Transient” Topographic Quantitative EEG Profile Identical to the “Persistent” Profile Seen in Chronic Heavy Users

Frederick A. Struve; Barbara R. Manno; Philip M. Kemp; Gloria Patrick; Joseph E. Manno

In two published pilot studies and a controlled replication using screened normals, chronic marihuana (THC) use was associated with a unique topographic quantitative EEG profile, consisting of significant elevations of Absolute and Relative Power and Coherence of alpha activity over the bilateral frontal cortex as well as a significant decrease in alpha frequency. This report attempts to establish the causal influence of THC in the above findings by the transient production of this exact quantitative EEG profile in subjects who did not display it at the beginning. Using paced smoking of marihuana with high and low dose THC content and placebo marihuana in a counterbalanced design under double blind conditions, all four of the topographic features of chronic THC exposure were produced as transient effects by THC but not by placebo.


Journal of Forensic Sciences | 2004

Screening Postmortem Whole Blood for Oxycodone by ELISA Response Ratios

Vina R. Spiehler; Lacinda DeCicco; J. Rod McCutcheon; Tom Kupiec; Philip M. Kemp

The objective of this study was to investigate the accuracy of screening postmortem whole blood for oxycodone using the ratio of the oxycodone immunoassay response to the response for the specimen obtained with a general opiate-class immunoassay. Fifty eight specimens which were negative for opiates and 158 postmortem whole blood specimens positive for opiates including 66 specimens known to contain oxycodone were assayed. Specimens were diluted 1:5 with assay buffer and analyzed by both the Neogen Oxymorphone/Oxycodone ELISA and the Neogen Opiate Group ELISA (Neogen Corporation, Lexington KY). The oxycodone equivalents in ng/mL from the Oxymorphone/Oxycodone ELISA were divided by the morphine equivalents in ng/mL from the Opiates ELISA to obtain an Oxycodone/Opiates Response Ratio. This ratio was compared with the GC/MS data for all specimens and for opiate positive specimens. Receiver Operating Characteristic (ROC) analysis suggested that optimum relative response ratio was 2.0. The sensitivity of the ELISA response ratio for the presence of oxycodone at a response ratio cutoff of 2.0 was 89.4% +/- 3.8% and the specificity was 88.1% +/- 3.2%. Specimens with a ratio of 2.0 or higher had a greater than 50% probability (positive predictive value) of containing oxycodone in a population with a greater than 15% prevalence of oxycodone.


Journal of Analytical Toxicology | 1995

Cannabinoids in Humans. II. The Influence of Three Methods of Hydrolysis on the Concentration of THC and Two Metabolites in Urine

Philip M. Kemp; Imad K. Abukhalaf; Joseph E. Manno; Barbara R. Manno; Dempsey D. Alford; Mary E. McWilliams; Frances Nixon; Mary Jo Fitz-Gerald; Roy R. Reeves; Mary J. Wood


Journal of Analytical Toxicology | 1995

Cannabinoids in Humans. I. Analysis of Δ9-Tetrahydrocannabinol and Six Metabolites in Plasma and Urine Using GC-MS

Philip M. Kemp; Imad K. Abukhalaf; Joseph E. Manno; Barbara R. Manno; Dempsey D. Alford; Gabi A. Abusada


Journal of Analytical Toxicology | 2001

Temporal Indication of Marijuana Use Can Be Estimated From Plasma and Urine Concentrations of Δ9-Tetrahydrocannabinol, 11-Hydroxy-Δ9-Tetrahydrocannabinol, and 11-Nor-Δ9-Tetrahydrocannabinol-9-Carboxylic Acid

Joseph E. Manno; Barbara R. Manno; Philip M. Kemp; Dempsey D. Alford; Imad K. Abukhalaf; Mary E. McWilliams; Frances N. Hagaman; Mary Jo Fitzgerald


Journal of Analytical Toxicology | 2002

Choice of an ELISA assay for screening postmortem blood for amphetamine and/or methamphetamine.

Tom Kupiec; Lacinda DeCicco; Vina R. Spiehler; Gary Sneed; Philip M. Kemp


Journal of Analytical Toxicology | 1997

Postmortem Distribution of Nicotine and Cotinine from a Case Involving the Simultaneous Administration of Multiple Nicotine Transdermal Systems

Philip M. Kemp; Gary Sneed; Cord E. George; Ronald F. Distefano


Journal of Analytical Toxicology | 2002

Validation of a microtiter plate ELISA for screening of postmortem blood for opiates and benzodiazepines.

Philip M. Kemp; Gary Sneed; Tom Kupiec; Vina R. Spiehler


Journal of Analytical Toxicology | 2003

Performance of a Microtiter Plate ELISA for Screening of Postmortem Blood for Cocaine and Metabolites

Vina R. Spiehler; Daniel S. Isenschmid; Parrish Matthews; Philip M. Kemp; Tom Kupiec


Journal of Analytical Toxicology | 1992

A Possible Association Between Fluoxetine Use and Suicide

Robert O. Bost; Philip M. Kemp

Collaboration


Dive into the Philip M. Kemp's collaboration.

Top Co-Authors

Avatar

Barbara R. Manno

Louisiana State University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Dempsey D. Alford

Louisiana State University

View shared research outputs
Top Co-Authors

Avatar

Imad K. Abukhalaf

Louisiana State University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Frances Nixon

Louisiana State University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge